Zur Institute, INNOVATIVE RESOURCES and ONLINE CONTINUING EDUCATION Sign In
New Users          

ONLINE CONTINUING EDUCATION FOR MENTAL HEALTH PROFESSIONALS

 

Feminists' New View of Women's Reproductive Health

Exposing How Pharmaceutical Companies Boost Drug Sales
by Inventing 'Medical Conditions' and 'Disorders'

Clinical Update
By Zur Institute

View a complete list of Clinical Updates.

 

Pharmaceutical companies have recently appointed themselves experts in the area of women's reproductive health.

Not feeling amorous? No problem.
Just pop this pill. Just use this cream.

Pharmaceutical ads urge women to reach for the drugs, and end with an image of a happily embracing couple. Moreover, to really boost sales, these companies employ both the carrot and the stick: that is, the promise of bliss and the fear of failure. In addition to guaranteeing instant romance, the companies must persuade consumers that any variation in desire indicates a medical condition. In other words, if you're not always ready for romance, you're suffering from a disease. Feminist researchers and clinicians have worked diligently to develop innovative ideas about these issues, and offer not only new definitions and descriptions, but have also designed alternative methods for optimizing women's reproductive health.

Access the complete Clinical Update and read more about this topic

 

Accommodations for Disabilities                   Clinical Updates Email Sign Up                  Refund & Course Exchange Policies


     

  APA NBCC NAADC ASWB

      Twitter Facebook LinkedIn YouTube

Online CE Courses
CE Board Approvals
60 Essential Clinical Forms
HIPAA Compliance Kit
Private Practice Handbook
Free Online Resources
Organizational Discounts
Site Map

Teaching
Consulting
Expert Witness
Issues Facing Teenagers
Boundaries & Dual Relationships
About Us
Info for the General Public
ADA Policy & Grievance
Privacy, Disclaimer, Terms of Use, DMCA


© 1995 - 2018 ZUR INSTITUTE, Inc.             Ofer Zur, Ph.D. Director             Contact Zur Institute, Inc.